Indena Reports Successful Outcome From FDA Inspection
4 Sep 2013 --- Indena announces that its French production site in Tours (France) successfully passed the US FDA inspection, with no FDA-483 issued, as per EIR (Establishment Inspection Report) received from the Center for Food Safety and Applied Nutrition of the FDA, confirming the company meets the new requirements mandated by the FDA Food Safety Modernization Act (FSMA).
The inspection involved the entire organization and focused on manufacturing operations, HACCP, sanification, cleaning, recall, complaint and training program and procedures.
“We are pleased with the successful outcome of the FDA inspection - said François Mairel, Indena Tours Plant Director – the audit covered the manufacturing of important products we are selling to our US customer base, like grape seed, olive polyphenolic and ginkgo biloba extracts and further confirms our commitment in giving our customers the highest standards of quality.”
Indena Tours already previously obtained the following certifications: GMP Certificate from the French Health Ministry – ANSM, HACCP, ISO 14001, Kosher, Halal certificate.
